唾液腺
Acquired abnormalities if the "FGFR1" gene are found in: ~14% of urinary bladder Transitional cell carcinomas (almost all are amplifications); ~10% of squamous cell Head and neck cancers (~80% amplifications, 20% other mutations); ~7% of endometrial cancers (half amplifications, half other types of mutations); ~6% of prostate cancers (half amplifications, half other mutations); ~5% of ovarian Papillary serous cystadenocarcinoma (almost all amplifications); ~5% of colorectal cancers (~60 amplifications, 40% other mutations); ~4% of sarcomas (mostly amplifications); &lt;3% of Glioblastomas (Fusion of "FGFR1" and "TACC1" (8p11) gene); &lt;3% of Salivary gland cancer (all amplifications); and &lt;2% in certain other cancers.